Melanoma patients had significantly higher SPRY4-IT1 expression in comparison to healthy patients and furthermore higher SPRY4-IT1 levels were associated with lower overall survival as well as higher tumor stage (summarized in Table 1) [123]. The gene discussed is SPRY4; the disease is neoplasm.